Otsuka Pharmaceutical Co. Ltd. et al v. Hetero Labs Ltd. et al
| Otsuka Pharmaceutical Co. Ltd. and H. Lundbeck A/S |
| Hetero Labs Ltd., Honour Lab Ltd., Hetero Drugs Ltd., Hetero Labs Limited Unit-V and Hetero USA, Inc. |
| 1:2020cv01531 |
| November 13, 2020 |
| US District Court for the District of Delaware |
| Leonard P Stark |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on January 6, 2021. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Pro Hac Vice Attorneys Kenneth S. Canfield and Dmitry V. Shelhoff for Hetero Drugs Ltd., Hetero Labs Limited Unit-V, Hetero Labs Ltd., Hetero USA, Inc., Honour Lab Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
| Filing 14 MOTION for Pro Hac Vice Appearance of Attorney Kenneth S. Canfield, Attorney Edward D. Pergament, and Attorney Dmitry V. Shelhoff - filed by Biophore India Pharmaceuticals Private Ltd., Zenara Pharma Private Ltd., Hetero Drugs Ltd., Hetero Labs Limited Unit-V, Hetero Labs Ltd., Hetero USA, Inc., Honour Lab Ltd.. (Dorsney, Kenneth) |
SO ORDERED, re (14 in 1:20-cv-01365-LPS, 8 in 1:20-cv-01287-LPS, 13 in 1:20-cv-01296-LPS, 9 in 1:20-cv-01599-LPS, 7 in 1:20-cv-01428-LPS, 12 in 1:20-cv-01423-LPS, 11 in 1:20-cv-01335-LPS, 10 in 1:20-cv-01295-LPS, 7 in 1:20-cv-01581-LPS, 7 in 1:20-cv-01502-LPS, 7 in 1:20-cv-01763-LPS, 10 in 1:20-cv-01297-LPS, 11 in 1:20-cv-01332-LPS, 13 in 1:20-cv-01531-LPS) MOTION for Pro Hac Vice Appearance of Attorney James B. Monroe, Denise Main, Erin M. Sommers, C. Collette Corser and Tyler B. Latcham filed by Otsuka Pharmaceutical Co.,Ltd, Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S, Otsuka Pharmaceutical Co. Ltd., H. Lundbeck A/S. Signed by Judge Leonard P. Stark on 1/5/21. Associated Cases: 1:20-cv-01287-LPS et al. (ntl)
|
|
SO ORDERED, re (14 in 1:20-cv-01531-LPS, 10 in 1:20-cv-01599-LPS) MOTION for Pro Hac Vice Appearance of Attorney Kenneth S. Canfield, Attorney Edward D. Pergament, and Attorney Dmitry V. Shelhoff filed by Hetero Labs Limited Unit-V, Biophore India Pharmaceuticals Private Ltd., Zenara Pharma Private Ltd., Hetero USA, Inc., Honour Lab Ltd., Hetero Labs Ltd., Hetero Drugs Ltd. Signed by Judge Leonard P. Stark on 1/5/21. Associated Cases: 1:20-cv-01531-LPS, 1:20-cv-01599-LPS (ntl)
|
| Filing 13 MOTION for Pro Hac Vice Appearance of Attorney James B. Monroe, Denise Main, Erin M. Sommers, C. Collette Corser and Tyler B. Latcham - filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd., Otsuka Pharmaceutical Co.,Ltd, Otsuka Pharmaceutical Co. Ltd., H. Lundbeck A/S. (Mayo, Andrew) |
| Filing 12 NOTICE of Withdrawal of Motion by Honour Lab Ltd. re #7 MOTION to Dismiss for Failure to State a Claim (Dorsney, Kenneth) |
| Filing 11 ANSWERING BRIEF in Opposition re #7 MOTION to Dismiss for Failure to State a Claim filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co. Ltd..Reply Brief due date per Local Rules is 12/10/2020. (Balick, Steven) |
| Filing 10 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Honour Lab Ltd.. (Hitch, Cortlan) |
| Filing 9 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Hetero Labs Ltd., Corporate Parent Hetero Drugs Ltd. for Hetero USA, Inc. filed by Hetero Drugs Ltd., Hetero Labs Limited Unit-V, Hetero Labs Ltd., Hetero USA, Inc.. (Hitch, Cortlan) |
| Filing 8 ANSWER to #1 Complaint, by Hetero Drugs Ltd., Hetero Labs Limited Unit-V, Hetero Labs Ltd., Hetero USA, Inc., Honour Lab Ltd..(Hitch, Cortlan) |
| Filing 7 MOTION to Dismiss for Failure to State a Claim - filed by Honour Lab Ltd.. (Dorsney, Kenneth) |
| Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. (rjb) |
| Filing 6 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by H. Lundbeck. (myr) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Otsuka Holdings Co., Ltd. for Otsuka Pharmaceutical Co. Ltd. filed by Otsuka Pharmaceutical Co. Ltd.. (myr) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US RE48,059. (myr) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: October 2, 2020. Date of Expiration of Patent: April 12, 2026; pending Patent Term Extension request, when granted, extends to December 23, 2028.Thirty Month Stay Deadline: 1/10/2023. (myr) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (myr) |
| Filing 1 COMPLAINT FOR PATENT INFRINGEMENT filed against Hetero Labs Limited Unit-V, Hetero Labs Ltd., Hetero USA, Inc., Honour Lab Ltd.,Hetero Drugs Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number ADEDC-3331208.) - filed by Otsuka Pharmaceutical Co. Ltd., H. Lundbeck. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(myr) |
| No Summons Issued. (myr) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
